Latest Insider Transactions at Renaissancere Holdings LTD (RNR)
This section provides a real-time view of insider transactions for Renaissancere Holdings LTD (RNR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RENAISSANCERE HOLDINGS LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RENAISSANCERE HOLDINGS LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Henry Klehm Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+5.13%
|
-
|
|
Mar 01
2022
|
David C Bushnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+4.94%
|
-
|
|
Mar 01
2022
|
Carol P Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+12.97%
|
-
|
|
Mar 01
2022
|
Duncan P Hennes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+15.23%
|
-
|
|
Mar 01
2022
|
Cynthia Trudell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+22.05%
|
-
|
|
Mar 01
2022
|
Brian Gerald John Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+6.2%
|
-
|
|
Mar 01
2022
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,162
-0.79%
|
$313,490
$145.49 P/Share
|
|
Mar 01
2022
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,752
+11.29%
|
-
|
|
Mar 01
2022
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,196
+13.82%
|
-
|
|
Mar 01
2022
|
Shannon Lowry Bender EVP, General Counsel & Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-4.37%
|
$26,390
$145.49 P/Share
|
|
Mar 01
2022
|
Shannon Lowry Bender EVP, General Counsel & Secty |
BUY
Grant, award, or other acquisition
|
Direct |
2,199
+34.55%
|
-
|
|
Mar 01
2022
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+19.09%
|
-
|
|
Mar 01
2022
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,647
-0.92%
|
$383,815
$145.49 P/Share
|
|
Mar 01
2022
|
Ian D Branagan EVP, Group Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,184
+11.0%
|
-
|
|
Mar 01
2022
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,684
+6.13%
|
-
|
|
Mar 01
2022
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,781
-0.42%
|
$838,245
$145.49 P/Share
|
|
Mar 01
2022
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,702
+8.85%
|
-
|
|
Mar 01
2022
|
Valerie Rahmani Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+15.23%
|
-
|
|
Feb 04
2022
|
Ross Curtis EVP,Chief Portfolio Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,426
-1.86%
|
-
|
|
Feb 04
2022
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,666
-4.52%
|
-
|
|
Feb 04
2022
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,091
-3.59%
|
-
|
|
Feb 04
2022
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,282
-4.14%
|
-
|
|
Dec 31
2021
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,689
-2.98%
|
$285,441
$169.33 P/Share
|
|
Dec 31
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,966
-3.27%
|
$332,254
$169.33 P/Share
|
|
Dec 31
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,894
-3.24%
|
$1,334,086
$169.33 P/Share
|
|
Nov 05
2021
|
Henry Klehm Iii Director |
SELL
Open market or private sale
|
Direct |
1,300
-6.53%
|
$200,200
$154.72 P/Share
|
|
Oct 29
2021
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+4.38%
|
$217,500
$145.01 P/Share
|
|
Oct 29
2021
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Open market or private purchase
|
Direct |
6,900
+1.33%
|
$993,600
$144.13 P/Share
|
|
Oct 29
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
BUY
Open market or private purchase
|
Direct |
3,440
+1.43%
|
$491,920
$143.8 P/Share
|
|
Oct 29
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+1.54%
|
$2,160,000
$144.13 P/Share
|
|
Oct 29
2021
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,400
+1.5%
|
$489,600
$144.13 P/Share
|
|
May 26
2021
|
Henry Klehm Iii Director |
SELL
Bona fide gift
|
Direct |
280
-1.39%
|
-
|
|
Apr 21
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
BUY
Bona fide gift
|
Indirect |
1,371
+50.0%
|
-
|
|
Apr 21
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Bona fide gift
|
Indirect |
4,113
-100.0%
|
-
|
|
Mar 01
2021
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,552
+14.34%
|
-
|
|
Mar 01
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,748
-4.88%
|
$1,961,916
$167.29 P/Share
|
|
Mar 01
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,660
-0.46%
|
$916,920
$162.61 P/Share
|
|
Mar 01
2021
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,122
+8.32%
|
-
|
|
Mar 01
2021
|
Anthony M Santomero Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+4.67%
|
-
|
|
Mar 01
2021
|
Henry Klehm Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+4.51%
|
-
|
|
Mar 01
2021
|
David C Bushnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+4.67%
|
-
|
|
Mar 01
2021
|
Cynthia Trudell Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+26.09%
|
-
|
|
Mar 01
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-1.19%
|
$453,276
$162.61 P/Share
|
|
Mar 01
2021
|
Ian D Branagan EVP, Group Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,506
+10.64%
|
-
|
|
Mar 01
2021
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,257
-1.03%
|
$365,634
$162.61 P/Share
|
|
Mar 01
2021
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,179
+11.11%
|
-
|
|
Mar 01
2021
|
James L Gibbons Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+6.95%
|
-
|
|
Mar 01
2021
|
Brian Gerald John Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+5.95%
|
-
|
|
Mar 01
2021
|
Shannon Lowry Bender EVP, General Counsel & Secty |
BUY
Grant, award, or other acquisition
|
Direct |
1,967
+50.0%
|
-
|
|
Mar 01
2021
|
Valerie Rahmani Director |
BUY
Grant, award, or other acquisition
|
Direct |
953
+16.39%
|
-
|